Table 1.
Open in new tab

Definition of experimental conditions used in this study

ConditionAbbreviationAnti-CD3/CD28 agonistMetabolic inhibitorPuromycin
No puromycin negative controlN-Co✓DMSO✗
Unactivated controlUA-Co✗DMSO✓
Positive controlP-Co✓DMSO✓
2DG2DG✓2DG✓
OMAOMA✓OMA✓
DGODGO✓2DG & OMA✓
ConditionAbbreviationAnti-CD3/CD28 agonistMetabolic inhibitorPuromycin
No puromycin negative controlN-Co✓DMSO✗
Unactivated controlUA-Co✗DMSO✓
Positive controlP-Co✓DMSO✓
2DG2DG✓2DG✓
OMAOMA✓OMA✓
DGODGO✓2DG & OMA✓
Table 1.
Open in new tab

Definition of experimental conditions used in this study

ConditionAbbreviationAnti-CD3/CD28 agonistMetabolic inhibitorPuromycin
No puromycin negative controlN-Co✓DMSO✗
Unactivated controlUA-Co✗DMSO✓
Positive controlP-Co✓DMSO✓
2DG2DG✓2DG✓
OMAOMA✓OMA✓
DGODGO✓2DG & OMA✓
ConditionAbbreviationAnti-CD3/CD28 agonistMetabolic inhibitorPuromycin
No puromycin negative controlN-Co✓DMSO✗
Unactivated controlUA-Co✗DMSO✓
Positive controlP-Co✓DMSO✓
2DG2DG✓2DG✓
OMAOMA✓OMA✓
DGODGO✓2DG & OMA✓
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close